John J.P. Kastelein
John J.P. Kastelein publishes mostly in Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine, on topics such as Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins and Lipid metabolism and disorders.
- World rank
- #3,566,030 of 7,710,434 ranked researchers
- Rank in Netherlands
- #70,332 of 107,149
- Works
- 65
- Citations
- 1.7k
- Citations per work
- 26.2
What does John J.P. Kastelein research?
John J.P. Kastelein's work is mostly in Medicine (54%), Biochemistry, Genetics and Molecular Biology (15%), Immunology and Microbiology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3553.8%
- Medicine3553.8%
- Everything else1828.4%
- Life Sciences1217.8%
- 1Surgery23% of their works
- 2Endocrinology, Diabetes and Metabolism17% of their works
- 3Cardiology and Cardiovascular Medicine14% of their works
- 4Cancer Research8% of their works
- 5Molecular Biology7% of their works
- 6Immunology3% of their works
Research topics
- Lipoproteins and Cardiovascular Health
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Lipid metabolism and disorders
- Cancer, Lipids, and Metabolism
- Peroxisome Proliferator-Activated Receptors
- Cardiovascular Health and Disease Prevention
- Cardiovascular Disease and Adiposity
- PARP inhibition in cancer therapy
Which keywords describe John J.P. Kastelein's research?
The keywords of their largest research topics: Statins, Atherosclerosis, Metabolic Syndrome, Cardiovascular Disease Prevention, Cholesterol, Cholesterol-lowering, Obesity and Diabetes.
- Perivascular Adipose Tissue
- Epicardial Fat
- BRCA Mutation
- Peroxisome Proliferator-Activated Receptors
- Inflammation
- Fatty Acid Synthase
- ANGPTL3
- Glucose Metabolism
- Diabetes
- Cholesterol-lowering
- Cardiovascular Disease Prevention
- Atherosclerosis
- Statins
- Metabolic Syndrome
- Cholesterol
- Obesity
- Cardiovascular Disease
- Insulin Resistance
- Lipoprotein Lipase
- Lipid Metabolism
- PPARs
- Arterial Stiffness
- Endothelial Dysfunction
- PARP Inhibitors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 24 words, with their numbers
- Statins412 topics
- Atherosclerosis383 topics
- Metabolic Syndrome352 topics
- Cardiovascular Disease Prevention311 topic
- Cholesterol312 topics
- Cholesterol-lowering311 topic
- Obesity293 topics
- Diabetes262 topics
- Cardiovascular Disease242 topics
- Glucose Metabolism211 topic
- Insulin Resistance211 topic
- ANGPTL3141 topic
- Lipoprotein Lipase141 topic
- Fatty Acid Synthase101 topic
- Lipid Metabolism101 topic
- Inflammation82 topics
- PPARs51 topic
- Peroxisome Proliferator-Activated Receptors51 topic
- Arterial Stiffness31 topic
- BRCA Mutation31 topic
- Endothelial Dysfunction31 topic
- Epicardial Fat31 topic
- PARP Inhibitors31 topic
- Perivascular Adipose Tissue31 topic
Where does John J.P. Kastelein work?
John J.P. Kastelein's main affiliation in the publication record is Amsterdam UMC Location University of Amsterdam, Netherlands.
How many publications and citations does John J.P. Kastelein have?
OpenAlex counts 65 works and 1,700 citations for John J.P. Kastelein, an h-index of 16, ranking #3,566,030 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named John J.P. Kastelein
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about John J.P. Kastelein. Posts are plain text and can be reported.